BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jiang Z, Fu L, Xu Y, Hu X, Yang H, Zhang Y, Luo H, Gan S, Tao L, Liang G, Shen X. Cyclovirobuxine D protects against diabetic cardiomyopathy by activating Nrf2-mediated antioxidant responses. Sci Rep. 2020;10:6427. [PMID: 32286474 DOI: 10.1038/s41598-020-63498-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Bailly C, Zhang J. A new horizon for the steroidal alkaloid cyclovirobuxine D (huangyangning) and analogues: Anticancer activities and mechanism of action. Journal of Traditional Chinese Medical Sciences 2020;7:337-44. [DOI: 10.1016/j.jtcms.2020.10.002] [Reference Citation Analysis]
2 Li Y, Zhang Z, Li S, Yu T, Jia Z. Therapeutic Effects of Traditional Chinese Medicine on Cardiovascular Diseases: the Central Role of Calcium Signaling. Front Pharmacol 2021;12:682273. [PMID: 34305595 DOI: 10.3389/fphar.2021.682273] [Reference Citation Analysis]
3 Rajbhandari J, Fernandez CJ, Agarwal M, Yeap BXY, Pappachan JM. Diabetic heart disease: A clinical update. World J Diabetes 2021;12:383-406. [PMID: 33889286 DOI: 10.4239/wjd.v12.i4.383] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 8] [Article Influence: 12.0] [Reference Citation Analysis]
4 Liu F, Feng M, Xing J, Zhou X. Timosaponin alleviates oxidative stress in rats with high fat diet-induced obesity via activating Nrf2/HO-1 and inhibiting the NF-κB pathway. Eur J Pharmacol 2021;909:174377. [PMID: 34302815 DOI: 10.1016/j.ejphar.2021.174377] [Reference Citation Analysis]
5 Duan JY, Lin X, Xu F, Shan SK, Guo B, Li FX, Wang Y, Zheng MH, Xu QS, Lei LM, Ou-Yang WL, Wu YY, Tang KX, Yuan LQ. Ferroptosis and Its Potential Role in Metabolic Diseases: A Curse or Revitalization? Front Cell Dev Biol 2021;9:701788. [PMID: 34307381 DOI: 10.3389/fcell.2021.701788] [Reference Citation Analysis]
6 Liu H, Zhang Z, Zhang L, Yao X, Zhong X, Cheng G, Wang L, Wan Q. Spiraeoside protects human cardiomyocytes against high glucose-induced injury, oxidative stress, and apoptosis by activation of PI3K/Akt/Nrf2 pathway. J Biochem Mol Toxicol 2020;34:e22548. [PMID: 32602595 DOI: 10.1002/jbt.22548] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 Gao G, Fu L, Xu Y, Tao L, Guo T, Fang G, Zhang G, Wang S, Qin T, Luo P, Shen X. Cyclovirobuxine D Ameliorates Experimental Diabetic Cardiomyopathy by Inhibiting Cardiomyocyte Pyroptosis via NLRP3 in vivo and in vitro. Front Pharmacol 2022;13:906548. [DOI: 10.3389/fphar.2022.906548] [Reference Citation Analysis]